The Saudi Food and Drug Authority (SFDA) has announced a new regulatory mandate prohibiting the sale of cosmetic products for external use in syringe-style packaging. The ban, which takes effect on January 1, 2027, is designed to eliminate the risk of consumers confusing topical beauty products with injectable pharmaceutical medications.
In a formal circular issued to importers and manufacturers, the SFDA noted that it had identified various cosmetic items being marketed in containers that mimic medical tools, specifically syringes, ampoules, and vials. To mitigate public health risks, the authority is also banning any promotional or advertising materials that imply these products can be administered via injection or any device capable of penetrating the skin.
While the use of syringe-style packaging will be entirely outlawed, the sale of cosmetics in ampoules and vials will remain permitted under stricter labeling requirements. These products must feature clear, prominent warnings in both Arabic and English, explicitly stating that the contents are intended for external cosmetic use only and must never be injected.
Furthermore, the updated labeling regulations require manufacturers to include specific safety warnings advising users to avoid eye contact and to exercise caution when opening the containers. These measures are part of a broader effort by the Saudi government to ensure consumer safety and prevent the misuse of non-medical products.
Industry stakeholders, including importers and manufacturers, have been granted a grace period until December 31, 2026, to either withdraw non-compliant products from the market or update their packaging to meet the new standards. The SFDA has warned that it will initiate legal action against any establishments or products found to be in violation of these rules once the deadline passes.
This regulatory shift follows a series of recent enforcement actions by the SFDA, including the suspension of a medical practitioner over the use of exosomes and the establishment of new guidelines regarding medicines carried by pilgrims. Additionally, the authority recently imposed fines totaling SR1.7 million on 10 pharmacies for various regulatory breaches.
The move to regulate cosmetic packaging is part of a wider administrative push in the Kingdom to tighten standards across health and commercial sectors. Other recent developments in the region include the recall of baby bottles due to choking hazards, the banning of sacred names on consumer packaging, and significant commercial milestones, such as the rapid sale of Dh1.25 billion in Bashayer homes and the record-breaking $4.9 million sale of Pelé’s 1958 World Cup jersey.
Manufacturers, importers and other establishments have been given until December 31, 2026, to withdraw products covered by the circular from the market or make the necessary changes to bring them into compliance with the
Source: Gulf News
